PXD042352 is an
original dataset announced via ProteomeXchange.
Dataset Summary
Title | Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics |
Description | Targeted protein degradation (TPD), as exemplified by proteolysis-targeting chimera (PROTAC), is a prominent paradigm in drug discovery. In this study, we applied conventional and novel PROTAC approaches to develop broad-spectrum antivirals (targeting key host factors for many different viruses) and virus-specific antivirals (targeting unique viral proteins). With respect to host-directed antivirals, we identified a small molecule degrader, FM-74-103, with pan-antiviral activities, as shown by inhibiting both RNA and DNA viruses. FM-74-103 elicits the selective degradation of human GSPT1, a translation termination factor, which further shuts down translation initiation. With respect to virus-specific antivirals, we developed viral RNA oligonucleotide-based bifunctional molecules (Destroyers). We provided proof-ofprinciple that RNA mimics of viral promoter sequences can be used as molecular glues to recruit viral polymerase (vPOL) and target it for degradation. Collectively, this study shows that TPD can be exploited to rationally design and develop the next generations of antivirals. |
HostingRepository | PRIDE |
AnnounceDate | 2023-11-14 |
AnnouncementXML | Submission_2023-11-14_06:42:25.952.xml |
DigitalObjectIdentifier | |
ReviewLevel | Peer-reviewed dataset |
DatasetOrigin | Original dataset |
RepositorySupport | Unsupported dataset by repository |
PrimarySubmitter | Jeffrey Johnson |
SpeciesList | scientific name: Homo sapiens (Human); NCBI TaxID: 9606; |
ModificationList | No PTMs are included in the dataset |
Instrument | Orbitrap Eclipse |
Dataset History
Revision | Datetime | Status | ChangeLog Entry |
0 | 2023-05-18 22:05:50 | ID requested | |
1 | 2023-06-15 10:43:50 | announced | |
⏵ 2 | 2023-11-14 06:42:26 | announced | 2023-11-14: Updated project metadata. |
Publication List
Dataset with its publication pending |
Keyword List
submitter keyword: PROTAC |
Influenza |
SARS-CoV-2 |
CMV |
GSPT1 |
Oligonucleotide |
Antiviral Therapeutics |
Contact List
Jeffrey R Johnson |
contact affiliation | Microbiology Department at the Icahn School of Medicine at Mount Sinai |
contact email | jeffrey.johnson@mssm.edu |
lab head | |
Jeffrey Johnson |
contact affiliation | Icahn School of Medicine at Mount Sinai |
contact email | jeffrey.johnson@mssm.edu |
dataset submitter | |
Full Dataset Link List
Dataset FTP location
NOTE: Most web browsers have now discontinued native support for FTP access within the browser window. But you can usually install another FTP app (we recommend FileZilla) and configure your browser to launch the external application when you click on this FTP link. Or otherwise, launch an app that supports FTP (like FileZilla) and use this address: ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2023/06/PXD042352 |
PRIDE project URI |
Repository Record List
[ + ]
[ - ]
- PRIDE
- PXD042352
- Label: PRIDE project
- Name: Generation of host-directed and virus-specific antivirals using targeted protein degradation promoted by small molecules and viral RNA mimics